FREE Account Opening + No Clearing Fees
Loading...

Dipna Pharmachem IPO vs EP Biocomposites IPO

Comparision between Dipna Pharmachem IPO and EP Biocomposites IPO.

IPO Details

Dipna Pharmachem IPO is a SME Fixed Price Issue IPO proposed to list at BSE SME while EP Biocomposites IPO is a SME Fixed Price Issue proposed to list at BSE SME.

  Dipna Pharmachem IPO EP Biocomposites IPO
Logo Dipna Pharmachem IPO Logo EP Biocomposites IPO Logo
Issue Category SME SME
Issue Type IPO IPO
Process Type Fixed Price Issue Fixed Price Issue
Listing At BSE SME BSE SME
Lead Managers Interactive Financial Services Ltd Aryaman Financial Services Limited
Registrar Bigshare Services Pvt Ltd Bigshare Services Pvt Ltd
Market Maker
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor
IPO Allotment URL IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Dipna Pharmachem IPO is up to ₹15.21 Cr whereas the issue size of the EP Biocomposites IPO is up to ₹6.35 Cr. The final issue price of Dipna Pharmachem IPO is ₹38.00 per share and of EP Biocomposites IPO is ₹126.00 per share.

  Dipna Pharmachem IPO EP Biocomposites IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower)
Issue Price (Upper)
Issue Price (Final) ₹38.00 per share ₹126.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 3000 shares 1000 shares
Fresh Issue Size 40,02,000 shares 5,04,000 shares
Fresh Issue Size (Amount) up to ₹15.21 Cr up to ₹6.35 Cr
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total 40,02,000 shares 5,04,000 shares
Issue Size Total (Amount) up to ₹15.21 Cr up to ₹6.35 Cr

IPO Timetable

Dipna Pharmachem IPO opens on Aug 25, 2022, while EP Biocomposites IPO opens on Aug 29, 2022. The closing date of Dipna Pharmachem IPO and EP Biocomposites IPO is Aug 30, 2022, and Sep 05, 2022, respectively.

  Dipna Pharmachem IPO EP Biocomposites IPO
Anchor Bid Date
Issue Open Aug 25, 2022 Aug 29, 2022
Issue Close Aug 30, 2022 Sep 05, 2022
Basis Of Allotment (Tentative) Sep 08, 2022
Initiation of Refunds (Tentative) Sep 09, 2022
Credit of Share (Tentative) Sep 12, 2022
Listing date (Tentative) Sep 13, 2022
Anchor Lockin End date 1 Oct 08, 2022
Anchor Lockin End date 2 Dec 07, 2022

Financials

Dipna Pharmachem IPO P/E ratio is 39, as compared to EP Biocomposites IPO P/E ratio of 26.2.

  Dipna Pharmachem IPO EP Biocomposites IPO
Financial
Dipna Pharmachem Limited Financial Information (Restated)
Period EndedTotal AssetsTotal RevenueProfit After TaxNet WorthReserves and Surplus
31-Mar-201844.183054.855.954.7551.25
31-Mar-212479.343101.542.4257.1753.67
31-Mar-223622.967276.58116.69173.86170.36
Amount in ₹ Lakhs
EP Biocomposites Limited Financial Information (Restated)
Period EndedTotal AssetsTotal RevenueProfit After TaxNet WorthReserves and Surplus
31-Mar-2055.1656.833.152.85-2.15
31-Mar-21132.38295.2335.838.6533.65
31-Mar-22927.69807.5580.94199.8482.09
Amount in ₹ Lakhs
Promoter Shareholding (Pre-Issue) 100% 98.97%
Promoter Shareholding (Post-Issue) 66.56% 69.40%
P/E Ratio 39 26.2
Market Cap ₹45.49 Cr. ₹21.19 Cr.
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Dipna Pharmachem IPO retail investors (RII) are offered 18,99,000 shares while in EP Biocomposites IPO retail investors are offered 18,99,000 shares. Qualified institutional buyers (QIB) are offered in Dipna Pharmachem IPO and in EP Biocomposites IPO.

  Dipna Pharmachem IPO EP Biocomposites IPO
Anchor Investor Reserveration
Market Maker Reserveration 2,04,000 shares 28,000 shares
QIB
NII 18,99,000 shares 2,38,000 shares
RII 18,99,000 shares 2,38,000 shares
Employee
Others
Total 37,98,000 shares 4,76,000 shares

Bids Received (Subscription)

Dipna Pharmachem IPO subscribed 2.77x in total, whereas EP Biocomposites IPO subscribed 18.51x.

  Dipna Pharmachem IPO EP Biocomposites IPO
QIB (times)
NII (times) 0.78x 21.58x
Big NII (times)
Small NII (times)
RII (times) 4.75x 15.44x
Employee (times)
Other (times)
Total (times) 2.77x 18.51x

Comments

Add a public comment...